Novartis Gene Therapies’ Post

Learn the key strategies and insights shaping the landscape of gene therapies. A story (also a step by step manual) that we lived and every word written is a step towards helping more and more patients. #novartis #novartisgenetherapies #genetherapies #patients #rarediseases

Cell and gene therapies: common challenges for market access https://lnkd.in/g24Thxab The potential that cell and gene therapies have to offer in bringing personalized, targeted therapies into the forefront, must be tempered against the practical hurdles and realities observed in launching into the challenging therapy areas that cell and gene therapies tackle. In this update, we explore four common access challenges that have been observed in the cell and gene therapy space. https://lnkd.in/g24Thxab #HEOR #MarketAccess #WeAreAvalereHealth

What is needed to make Cell and Gene therapies commercially viable? In our latest article, we present new insights on the Cell and Gene therapy market. CGTs have the potential to revolutionize the treatment landscape and cure previously fatal diseases. The market for these therapies is expected to grow at an impressive compound annual growth rate of 46% over the next five years, reaching a total global market size of $37 billion. However, some challenges must be addressed for these therapies to be commercially sustainable. Dr. Oliver Eitelwein, Dr. Laura Jochem, Allegra Hohn-Honari. https://owy.mn/3QPj9Vt

Are you attending the International Society for Cell & Gene Therapy's (ISCT) Europe Regional Meeting in #Sweden? ➡️ https://buff.ly/4fnNGon Hear from Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult who will be speaking across the day sharing expert commentary into regulatory standards, the current use of iPSCs, and commercial development of cell and gene therapies. #CellTherapies #GeneTherapies

As cell and gene therapies rapidly advance, regulators, developers and manufacturers face a unique set of challenges to overcome. In our Spotlight feature on cell and gene therapy regulation, Sartorius explore the complexities of the regulatory landscape >>> https://hubs.ly/Q02LHFx60

Catalent Cell & Gene Therapy experts discuss how cell and gene therapies are changing the healthcare landscape and what needs to be done to bring these advanced therapies to patients. https://ow.ly/2CZW50QSEkX

🤔 IT'S TRIVIA TUESDAY AGAIN! 🤔 With gene therapy approvals rising, let's test your gene therapy knowledge. QUESTION: What was the first rare disease to be successfully treated with gene therapy? A) sickle cell disease B) hemophilia C) severe combined immunodeficiency (SCID) D) adrenoleukodystrophy Take your best guess and write it in the comments below 👇 #TuesdayTrivia #TriviaTuesday #FDA #genetherapy #clinicalresearch #innovation #consulting #FDAapprovals #raredisease

Navigating the evolving landscape of approved cell and gene therapies poses a challenge for the drug development community. Discover insights on aligning expectations and implementing effective bioanalytical strategies in our latest eBook. For more in-depth knowledge, explore our new Cell and Gene Therapy Accelerating Science Feature: https://lnkd.in/ea6_b8_v #genetherapy, #celltherapy, and #drugdevelopment. #AAPS #BiotechInsights

Learn about today’s top challenges in cell and gene therapy and how to solve them from Harm Niederländer at this year’s #ESACT. Explore more about Sartorius cell and gene therapy solutions: https://sar.to/7vnln #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy #ESACT2024

Want to learn more about gene therapies? Check out “Get to Know Gene Therapies for Sickle Cell Disease,” a panel discussion from National Heart, Lung, and Blood Institute's (NHLBI) Cure Sickle Cell Initiative (CureSCi) focused on gene therapies, the importance of being prepared for the procedure, and some of the mental health considerations involved with gene therapies. Watch now: https://lnkd.in/ei-4eUtr